The proportion of interns who met the 9-item Patient Health Questionnaire (PHQ-9) criteria for depression52 prior to internship and at 3-month intervals through the internship year.
Nine-item Patient Health Questionnaire (PHQ-9) depression scores in white subjects stratified by the presence of at least 1 copy of a 5-HTTLPR low-functioning allele. Error bars indicate standard error of the mean.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Sen S, Kranzler HR, Krystal JH, et al. A Prospective Cohort Study Investigating Factors Associated With Depression During Medical Internship. Arch Gen Psychiatry. 2010;67(6):557–565. doi:10.1001/archgenpsychiatry.2010.41
Although the prevalence of depression among medical interns substantially exceeds that of the general population, the specific factors responsible are not well understood. Recent reports of a moderating effect of a genetic polymorphism (5-HTTLPR) in the serotonin transporter protein gene on the likelihood that life stress will precipitate depression may help to understand the development of mood symptoms in medical interns.
To identify psychological, demographic, and residency program factors that are associated with depression among interns and to use medical internship as a model to study the moderating effects of this polymorphism.
A prospective cohort study.
Thirteen US hospitals.
Seven hundred forty interns entering participating residency programs.
Main Outcome Measures
Subjects were assessed for depressive symptoms using the 9-item Patient Health Questionnaire (PHQ-9), a series of psychological traits, and the 5-HTTLPR genotype prior to internship and then assessed for depressive symptoms and potential stressors at 3-month intervals during internship.
The PHQ-9 depression score increased from 2.4 prior to internship to a mean of 6.4 during internship (P < .001). The proportion of participants who met PHQ-9 criteria for depression increased from 3.9% prior to internship to a mean of 25.7% during internship (P < .001). A series of factors measured prior to internship (female sex, US medical education, difficult early family environment, history of major depression, lower baseline depressive symptom score, and higher neuroticism) and during internship (increased work hours, perceived medical errors, and stressful life events) was associated with a greater increase in depressive symptoms during internship. In addition, subjects with at least 1 copy of a less-transcribed 5-HTTLPR allele reported a greater increase in depressive symptoms under the stress of internship (P = .002).
There is a marked increase in depressive symptoms during medical internship. Specific individual, internship, and genetic factors are associated with the increase in depressive symptoms.Published online April 5, 2010 (doi:10.1001/archgenpsychiatry.2010.41).
Internship is known to be a time of high stress.1,2 New physicians are faced with long work hours, sleep deprivation, loss of autonomy, and extreme emotional situations.3 A series of cross-sectional studies has examined the prevalence of significant depressive symptoms among interns. Although the proportion of interns who screen positive for major depression varied markedly across these studies (7%-49%), most studies found rates of major depression among interns to be higher than the rates found in the general population (4%-5%).2,4-14
Prospective, longitudinal studies are necessary to understand the factors underlying the development of depression among interns. Prospective studies of depression during internship to date have yielded inconsistent findings; some studies reported that factors such as female sex, neuroticism, and medical errors were associated with increased depression, but other studies failed to replicate these results.12,15-22 A review of these studies concluded that it is difficult to draw firm conclusions because each of the studies had significant limitations.23 Most notably, the studies enrolled relatively small samples that were restricted to individual residency programs or institutions and suffered from high attrition rates and short follow-up periods.23 Furthermore, many potentially important factors, such as work hours and social support, have not been well explored in internship depression. We report herein on the largest longitudinal study to date of a sample of interns drawn from multiple institutions and specialties over a 14-month period. It aims to identify factors associated with the development of depression during internship.
Genetic epidemiological studies indicate that in addition to life stressors, genetic factors play a major role in the etiology of depression.24 The gene most extensively investigated in depression is SLC6A4, which encodes the serotonin transporter protein. The serotonin transporter is a transmembrane protein located on the presynaptic membrane of serotonergic neurons. It is a major target of many common antidepressant medications, such as selective serotonin reuptake inhibitors and tricyclic antidepressants.
Caspi and colleagues25 reported an interaction between a functional promoter polymorphism at this locus (5-HTTLPR) and life stress in the development of depression. They found that among subjects who experienced no life stressors, 5-HTTLPR was not associated with depressive symptoms. As the number of stressful life events reported by subjects increased, however, subjects with at least 1 copy of the less transcriptionally active (low-functioning) 5-HTTLPR short (S) allele reported significantly more depressive symptoms than subjects with 2 copies of the high-functioning 5-HTTLPR long (L) allele. To date, there have been (at least) 37 follow-up studies, with some studies supporting the presence of an interaction and others not.
Two recent meta-analyses have assessed a subset of these studies and concluded that there is no evidence supporting the presence of the interaction.26,27 It is important to note, however, that these meta-analyses have important limitations. First, in contrast to traditional genetic association studies, there is marked variation in study design among studies examining this interaction. Both meta-analyses were heavily weighted toward large studies in which stressful events were not well assessed, while discounting studies with more comprehensive assessments of stress that necessarily used smaller samples. Furthermore, even the larger of the 2 meta-analyses was able to include only 14 of the 38 published studies that examined the association between 5-HTTLPR, stress, and depression. The vast majority of the studies excluded by the meta-analysis reported that the presence of the 5-HTTLPR S allele increased the risk of depression under stress, suggesting that it is premature to draw definitive conclusions about the presence or absence of this interaction from these meta-analyses.28-47
The inconsistency among studies to date may be due in part to methodological limitations of some of these studies.48 First, most of the studies assessed stressful life events and depressive symptoms retrospectively and concurrently. For some studies, subjects were asked to recall stressors and putative depressive episodes that occurred many years before the interview.49,50 This is problematic because the induction of depressed mood significantly increases the recall of stressful life events.51 Furthermore, individuals with a history of depression experience perceived more stressful life events than healthy individuals.52 As a result, many of the studies to date do not adequately disentangle the cause and effect relationship between depression and reports of life stress. Additionally, most previous studies assessed a set of life stressors that were highly variable in character and intensity. Combining quantitatively and qualitatively disparate stressors may act to increase the “noise” of a study, reducing its statistical power to detect interaction effects.
Some studies have attempted to avoid the problems of impaired recall and variable stressors by focusing on specific populations that have experienced a substantial, uniform stressor, such as stroke or myocardial infarction.37-46 However, because these specific stressor studies assess subjects only after the onset of the stressor, they cannot determine whether the depression was present before the onset of the stressor or whether the depression played a role in precipitating the stressor. Although one could study this question prospectively, with depression measured in the same subjects before and after the onset of a uniform stressor, it is generally not possible to predict the occurrence of a stressor. Medical internship provides a rare instance in which the onset of a major stressor can be predicted for a defined population. The present study seeks to identify the factors important in the development of depression during medical internship and to use internship as a stress model to study subjects before and after the onset of a major stressor and assess the moderating effect of 5-HTTLPR on the development of depression.
One thousand three hundred ninety-four interns entering traditional and primary care internal medicine, general surgery, pediatrics, obstetrics/gynecology, and psychiatry residency programs during the 2007-2008 and 2008-2009 academic years were sent an e-mail 2 months prior to commencing internship and invited to participate in the study. For 123 subjects, our e-mail invitations were returned as undeliverable and we were unable to obtain a valid e-mail address. Seven hundred forty (n = 1271 [58%]) of the remaining invited subjects agreed to participate in the study. The institutional review board at Yale University and the participating hospitals approved the study. Participating subjects provided electronic informed consent. Subjects were given $30 (2007-2008 cohort) or $40 (2008-2009 cohort) gift certificates.
All surveys were conducted through a secure Web site designed to maintain confidentiality, with subjects identified only by numbers. No links between the identification number and the subjects' identities were maintained.
Depressive symptoms were measured using the depression module of the 9-item Patient Health Questionnaire (PHQ-9).53 The PHQ-9 is a self-report component of the Primary Care Evaluation of Mental Disorders inventory, which is designed to screen for depressive symptoms. For each of the 9 depressive symptoms, interns indicated whether, during the previous 2 weeks, the symptom had bothered them “not at all,” “several days,” “more than half the days,” or “nearly every day.” Each item yields a score of 0 to 3, so that the PHQ-9 total score ranges from 0 to 27; PHQ-9 scores of 10 to 14, 15 to 19, and 20 or greater correspond to moderate, moderately severe, and severe depression, respectively.54 A score of 10 or greater on the PHQ-9 has a sensitivity of 93% and a specificity of 88% for the diagnosis of major depressive disorder.54 Diagnostic validity of the PHQ-9 is comparable with clinician-administered assessments.53
Subjects completed a baseline survey 1 to 2 months prior to commencing internship. The survey assessed general demographic factors (age, sex, and marital status), medical education factors (American or foreign medical school and medical specialty), personal factors (baseline PHQ-9 depressive symptoms and self-reported history of depression) and the following psychological measures: (1) neuroticism (NEO-Five Factor Inventory55), (2) resilience (Connor-Davidson Resilience Scale56), (3) perceived stress (Perceived Stress Scale57), (4) social supports (Sarason Social Support Questionnaire58), (5) early family environment (Risky Families Questionnaire59), and (6) cognitive styles (modified Sociotropy-Autonomy Scale60). Subjects also self-reported their ethnicity from a set of options that the investigator provided.
Participants were contacted via e-mail at months 3, 6, 9, and 12 of their internship year and asked to complete the PHQ-9. They were also queried regarding their rotation setting, perceived medical errors, work hours, and sleep during the past week and the occurrence of a series of noninternship life stresses (serious illness; death or serious illness in a close family member or friend; financial problems; end of a serious relationship; and becoming a victim of crime or domestic violence) during the past 3 months.
Subjects choosing to take part in the study were given the option to submit a saliva sample for DNA extraction. We used the Oragene salivary DNA self-collection kit,61 which allows subjects to submit a salivary sample by mail without direct contact with study personnel.
The serotonin transporter 5-HTTLPR variant was genotyped using previously described polymerase chain reaction conditions and primers.62 An A→G single-nucleotide polymorphism has been identified within the 5-HTTLPR repeat region (rs25531).63 Functional studies have shown that promoter regions with the 16-repeat variant and the G allele (LG) were functionally equivalent to the low-functioning 14-repeat variant (S allele). To genotype the additional single-nucleotide polymorphism that occurs in the variable-number-tandem-repeat region of the SLC6A4 promoter,63 we used a restriction enzyme assay that was described previously.64
All analyses were performed using SPSS, version 16.0 (SPSS Inc, Chicago, Illinois). The point prevalence of depressive symptoms and a positive screen for depression during internship were determined through analysis of PHQ-9 depressive symptom scores at the 3-, 6-, 9-, and 12-month assessments. To investigate whether there was a significant change in depressive symptoms during the internship year, we compared baseline PHQ-9 depressive symptoms and depressive symptoms at the 3-, 6-, 9-, and 12-month assessments through a series of paired t tests.
The association between variables measured at baseline and the development of depressive symptoms during internship was assessed through a 2-step process. Using Pearson correlations for continuous measures and χ2 analyses for nominal measures, we identified baseline demographic variables that were associated with the mean change in depressive symptoms from baseline to the quarterly assessments during internship (change in PHQ-9 score = mean PHQ-9 depressive symptoms at 3-, 6-, 9- and 12-month assessments – PHQ-9 depressive symptoms at baseline). Significant variables were subsequently entered into a stepwise linear regression model to identify significant predictors while accounting for colinearity among variables.
The association between variables measured through recurring assessments during internship (within-internship variables) and change in depressive symptoms were assessed through a generalized estimating equation analysis to account for correlated repeated measures within subjects. Internship variables (work hours, occurrence of medical errors, hours of sleep, and noninternship stressful life events) were incorporated as predictor variables, and associated baseline factors were used as covariates. We used concurrently measured depressive symptoms as the outcome variable (ie, 3-month depressive symptoms were indexed to the 3-month within-internship variable, 6-month depressive symptoms were indexed to 6-month medical errors, etc).
Next, to gain insight into the direction of causality between associated within-internship factors and depressive symptoms, we assessed whether the depressive symptom score prior to internship predicted increased levels of the associated within-internship variables at 3 months. For this analysis, we used a general linear model, with the associated within-internship measure as the dependent variable and baseline depressive symptom score as the independent variable. Baseline factors associated with increased depressive symptoms were included as covariates. Finally, for the variables for which baseline depressive symptom score predicted increased levels of the associated within-internship variables at 3 months, we tested whether the 3-month depressive symptom score was associated with the relevant within-internship factor after controlling for baseline depressive symptoms. Thus, 3-month depressive symptom scores were reintroduced into the general linear model as an independent variable in the analysis.
Because there are substantial racial/ethnic differences in 5-HTTLPR allele frequencies (S allele frequency: Caucasian, 0.44; African, 0.11; and Chinese, 0.70),62 we performed separate analyses for individual racial/ethnic groups to minimize the chance of false association due to the presence of population stratification.65 To explore the effects of 5-HTTLPR and stress on the emergence of depressive symptoms, we performed a generalized estimating equation analysis with the presence of a 5-HTTLPR low-functioning allele (S or LG) as the grouping variable and change in depressive symptoms as the outcome variable. To gain insight into the specific factors that moderate a potential genotype effect on depressive symptoms, we introduced the baseline and within-internship factors that had significant main effects on this outcome measure in the previous analysis and the corresponding genotype × factor interaction terms as predictor variables into the generalized estimating equation analysis.
Individuals who chose to take part in the study were younger (27.9 vs 28.4 years; P < .001) and more likely to be female (54.4% vs 52.5%; P < .001) than individuals who chose not to participate (Table 1) (eTable 1, eTable 2, eTable 3, and eTable 4). Six hundred fifty-one (n = 740 [88%]) subjects completed at least 1 follow-up survey, with a mean of 69% of subjects responding to each of the 4 follow-up surveys.
The mean PHQ-9 depressive symptom score reported by subjects increased significantly from baseline (2.38 [SD, 2.99]) to 3 months (6.70 [SD, 5.37]; P < .001), 6 months (6.33 [SD, 4.98]; P < .001), 9 months (6.48 [SD, 4.98]; P < .001), and 12 months (6.26 [SD, 5.10]; P < .001) of internship. Using the criteria for major depression developed by Kroenke et al54 (PHQ-9 score ≥10), we found that the percentage of subjects meeting this diagnosis increased from 3.9% at baseline to 27.1%, 23.3%, 25.7%, and 26.6% at the 3-, 6-, 9-, and 12-month points of internship, respectively (Figure 1). We found that 41.8% of subjects met criteria for major depression at 1 or more quarterly assessments. On sensitivity analysis, assuming that all nonresponders did not experience a depressive episode during internship, the prevalence of a depressive episode during internship would be 19.5% (272 of 1394). The percentage of subjects meeting criteria for moderately severe depression (PHQ-9 score >15) increased from 0.7% at baseline to 6.6%, 6.2%, 7.8%, and 7.6% at the 3-, 6-, 9-, and 12-month points of the internship, respectively. Similarly, the percentage of subjects who met criteria for severe depression (PHQ-9 score >20) increased from 0% at baseline to 2.3%, 1.6%, 1.8%, and 0.8% at 3, 6, 9, and 12 months of internship, respectively.
To determine whether the increase in overall PHQ-9 score was due to an increase in all depressive symptoms or only a subset, we assessed the change from baseline to mean internship level individually for each of the PHQ-9 symptoms. Subjects reported a significant increase (P < .001) for all 9 items. The increase in mean symptom score ranged from 70% (difficulty sleeping) to 370% (thoughts of death).
Among 15 baseline variables tested, 9 were significantly correlated with a change in depressive symptoms from the baseline assessment to the mean of the 4 internship assessments (female sex, r = 0.147, P < .001; European American ethnicity, r = 0.084, P = .04; history of depression, r = 0.206, P < .001; lower baseline depressive symptoms, r = 0.126, P = .002; US medical education, r = 0.115, P = .004; higher neuroticism, r = 0.115, P < .001; difficult early family environment, r = 0.108, P < .001; higher perceived stress, r = 0.094, P = .02; and higher sociotropy, r = 0.116, P = .004). When these 9 variables were entered into the stepwise linear regression to account for colinearity between variables, 6 variables remained significant (neuroticism, β = 0.24, P < .001; personal history of depression, β = 0.17, P < .001; lower baseline depressive symptoms, β = 0.38, P < .001; female sex, β = 0.08, P = .03; US medical education, β = 0.10, P = .005; and difficult early family environment, β = 0.08, P = .04).
We used a generalized estimating equation analysis to assess factors during internship that were associated with a change in depressive symptoms while controlling for repeated measurements. Three within-internship variables were associated with an increase in depressive symptoms (work hours, Wald χ299 = 2.8 × 1011, P < .001; reported medical errors, Wald χ21 = 16.2, P < .001; and noninternship stressful life events, Wald χ25 = 71.6, P < .001). There were no significant sex interactions for any of the associated baseline or within-internship factors (data not shown) (Table 2).
To gain insight into the direction of the association of within-internship factors and depression, we assessed whether baseline depressive symptoms predicted an increased level of the within-internship factor at the 3-month internship assessment. Baseline depressive symptom score predicted reported medical errors at 3 months (F21 = 2.201, P = .002), but not work hours (F21 = 1.116, P = .22) or noninternship stressful life events (F21 = 1.029, P = .45) at 3 months. For the reported medical errors analysis, reintroduction of the 3-month depressive symptom score showed it to be a significant predictor of medical errors at 3 months even in the presence of baseline depressive symptoms (F27 = 1.676, P = .004).
A total of 409 of 652 (63%) eligible subjects provided saliva samples. There were no significant differences on sex, age, or ethnicity between subjects who provided a sample and those who did not. For both major racial/ethnic groups in our sample (European American and Asian), allele frequencies were consistent with previous reports and Hardy-Weinberg equilibrium (data not shown). Among European Americans, subjects with at least 1 low-functioning 5-HTTLPR (S or LG) allele reported a significantly greater increase in depressive symptoms than subjects with 2 high-functioning 5-HTTLPR (LA) alleles (Wald χ21 = 8.2, P = .004) (Figure 2). The percentage of European American subjects with at least 1 low-functioning 5-HTTLPR allele who met criteria for depression increased from 2.4% before internship to 42.5% at its highest during internship, while the percentage of European American subjects with 2 high-functioning 5-HTTLPR alleles who met criteria for depression increased from 5.1% before internship to 36.2% at its highest during internship (Table 3).
To identify variables that moderate the association between 5-HTTLPR and depressive symptoms, we introduced the main effect and interaction terms, consisting of genotype and each of the baseline and within-internship variables that were significantly associated with an increase in depressive symptoms into the 5-HTTLPR generalized estimating equation analysis. Among baseline variables, there was a significant interaction of 5-HTTLPR with neuroticism (Wald χ219 = 30.6, P = .045), but the interactions of 5-HTTLPR with the other 5 baseline variables were not significant. Among within-internship variables, there was a significant interaction of 5-HTTLPR with work hours (Wald χ261 = 5757.3, P < .001), but the interactions of 5-HTTLPR with noninternship stressful life events and reported medical errors were not significant. Among Asian subjects, there was no difference in the change in depressive symptoms between genotype groups (t = 1.06; P = .40).
In this study, we found that the rate of depression increased dramatically during the internship year, from 3.9% of subjects meeting PHQ-9 criteria for depression before internship to an average of 25.3% of subjects meeting criteria at quarterly assessments during the internship year. Most subjects who met criteria for depression were classified as moderately depressed, with few subjects meeting PHQ-9 criteria for moderately severe or severe depression. Because the development of major depression has been linked to a higher risk of future depressive episodes and greater long-term morbidity risk,66,67 future studies should examine how the rate of depression changes as training physicians progress through their careers beyond internship and the possible effects of depression on the general health of physicians.
Beyond assessing depression prevalence, we also identified a series of factors associated with the development of depressive symptoms during internship. The baseline factors that were associated with the development of depression in this study include some that have been implicated in prior residency studies (female sex, difficult early family environment, neuroticism, and a prior history of depression) and other factors not previously identified (US medical education and lower baseline depressive symptoms). It is also interesting to note that a number of factors, such as medical specialty and age, were not associated with the development of depression. With effective interventions to help prevent the onset of depression now available, the predictive factors identified herein could allow at-risk interns to take steps before the onset of symptoms to lower their chances of developing depression.68
As with baseline factors, we identified within-internship factors that were previously implicated as well as novel factors associated with the development of depression. Our finding that medical errors are associated with depression supports the findings of 2 recent studies.69,70 Herein, we extend the association identified in prior studies by demonstrating that depressive symptoms that are present before internship predicted reported errors during internship, indicating that depression results in increased medical errors. Controlling for the baseline level of depressive symptoms, a strong correlation between errors and depression persisted, indicating that errors may also cause depression and that the association between depression and reported medical errors is bidirectional.
In addition to building on previous work exploring the relationship between medical errors and depression, this is the first study to demonstrate a direct association between the number of hours worked and risk of depression in medical interns. In contrast to our finding with medical errors, we found no evidence that depressive symptom score before internship predicted one's work hours during internship. These findings suggest that increased work hours lead to increased depressive symptoms during internship. Future studies could explore whether systemic changes designed to improve patient safety, such as additional safeguards against medical errors and further resident work hours' restrictions, reduce the development of depression among interns.
There are a number of limitations to our findings related to depressive symptoms and internship. First, our finding that the association between depressive symptoms and reported medical errors persisted when controlling for preexisting depressive symptoms does not definitively prove that errors led to depression. It is possible that some third factor differentially promoted depression in a subset of the sample and also led to an increase in the reported within-internship factor in that group of residents. Although no variable that we measured (sex, age, specialty, or institution) appeared to account for this effect, it is possible that an unmeasured variable could have caused it.
Second, only 58% of invited individuals chose to participate in the study. Although there were only modest differences in age and sex between those who chose to take part in the study and those who did not, our results should be extrapolated with caution.
Third, although multiple studies have demonstrated the validity, sensitivity, and specificity of the PHQ-9 inventory, it is important to note that we assessed depression through a self-report inventory rather than a diagnostic interview.
Fourth, we assessed medical errors through self-report rather than through objective measurement, leading to the possibility that we did not accurately capture the occurrence of medical errors. For instance, the established tendency of depressed individuals toward enhanced memory of emotionally negative events may have resulted in depressed residents recalling more errors rather than actually committing more errors.24 Previous studies, however, have demonstrated that resident self-report of errors can act as a reasonable proxy for errors assessed through medical record review and that self-report was actually more effective in detecting preventable errors.71,72
Finally, our study was restricted to interns and thus our results may not hold for advanced residents or physicians who have completed their training. In addition, although we did not find significant differences in results among hospitals or specialties, the interns and programs included here may not represent the country in general.
In addition to identifying factors associated with the development of depression during internship, we also used internship as a model to explore the relationship between a serotonin transporter promoter polymorphism and stress in the development of depression. We found evidence that this variant moderates the response to stress in European American subjects, with subjects carrying at least 1 low-functioning 5-HTTLPR allele reporting a 43% greater increase in depressive symptoms than subjects with 2 high-functioning alleles. Consistent with an earlier study exploring the 5-HTTLPR × stress interaction in the context of personality traits, we found that the association between 5-HTTLPR and the development of depressive symptoms under stress was moderated by neuroticism.32 Furthermore, in exploring the type of stress for which 5-HTTLPR affects sensitivity, we found evidence supporting an interaction of 5-HTTLPR with work hours, but not with medical errors or stressful life events. This finding supports the results of a prior study in which the 5-HTTLPR × stress interaction effect on depressive symptoms was the result of increased sensitivity to common, mild stressors among individuals carrying the low-functioning allele, rather than an increased sensitivity to rare and severe life events.31 The association between 5-HTTLPR, stress, and depression has not been well studied in Asian populations. In our sample, there was no evidence that 5-HTTLPR genotype influenced the change in depression score among subjects of Asian ethnicity.
The results of our study support the original study that demonstrated an association between 5-HTTLPR, stress, and depression risk,25 but they conflict with the results of some other studies and 2 recent meta-analyses. It is possible that no actual interaction exists and the results of our study, along with the other studies reporting a significant interaction, are false-positives. However, because the approaches used in studies exploring the interaction vary substantially, an alternate explanation for our findings is that a true, but modest gene × environment interaction effect exists, but that certain study design features are necessary to detect the effect.73 Our study illustrates a number of features that may be important to maximize the power to detect gene × environment interaction effects. First, we used a stressor that has a substantial direct effect on depression. This is in contrast to many of the negative studies exploring this interaction that assessed a set of life stressors that were highly variable in character and intensity. Second, by using a prospective design, we minimized the biases inherent in the retrospective and concurrent assessment of stress and depressive symptoms present in other studies.
It is interesting to note that 8 of the 10 previous studies that avoided the problems of impaired recall and variable stressors by using a specific stressor approach have reported an association between the 5-HTTLPR S allele and increased depression under stress.37-46 Herein, we extend the results of that specific stressor group of studies by assessing the same subjects before and after the onset of the stressor. This allowed us to avoid the confounding attributable to differences between subjects that are inherent in case-control studies and demonstrate that the association between genotype and depressive symptoms was not present before the onset of the stressor. Last, we maximized the genetic information obtained from the locus of interest by genotyping the functional single-nucleotide polymorphism within the 5-HTTLPR locus and functionally classifying the low-functioning LG allele with the low-functioning S allele. The functional misclassification of alleles in some previous studies may also have reduced the power to detect interaction effects.
In summary, we conducted the largest prospective study to date of depression during medical internship. We identified a high level of depressive symptoms among interns and a series of baseline and within-internship factors that are associated with increased depressive symptoms in this population. Subsequent studies that more fully explore the consequences of depression among interns both on patients and the physicians in training themselves are needed. In this study, we also used internship to model the relationship between 5-HTTLPR, stress, and depression and found that the 5-HTTLPR low-functioning allele was associated with a significantly greater increase in depressive symptoms under stress. Our study highlights the striking variation in experimental design among studies of this interaction and the impact on the findings of these different designs. In the future, meta-analyses exploring the relationship between 5-HTTLPR, stress, and depression should account for this variation in study design and systematically assess whether heterogeneity of study design predicts the estimated overall effect.
Correspondence: Srijan Sen, MD, PhD, Department of Psychiatry, University of Michigan, 5061 Biomedical Sciences Research Bldg, 109 Zina Pitcher Place, Ann Arbor, MI 48109 (firstname.lastname@example.org).
Submitted for Publication: August 12, 2009; final revision received November 30, 2009; accepted December 15, 2009.
Published Online: April 5, 2010 (doi:10.1001/archgenpsychiatry.2010.41). This article was corrected on April 29, 2010.
Author Contributions: Dr Sen had full access to all of the data in the study and conducted the statistical analyses. He takes responsibility for the integrity of the data and the accuracy of the data analysis.
Financial Disclosure: Dr Kranzler reports consulting arrangements with Alkermes Inc, Ortho-McNeil Pharmaceuticals, Elbion Pharmaceuticals, Solvay Pharmaceuticals, and Sanofi-Aventis Pharmaceuticals and has received research support from Merck and Merck Company, Bristol-Myers Squibb Company, and Ortho-McNeil Pharmaceuticals. Dr Krystal reports consulting arrangements with Abbott Laboratories, Astra-Zeneca, Atlas Venture, Bristol-Meyers Squibb, Cypress Bioscience Inc, Eli Lilly and Co, Fidelity Biosciences, Forest Laboratories, Glaxo-SmithKline, Houston Pharma, Lohocla Research Corporation, Merz Pharmaceuticals, Organon Pharmaceuticals, Pfizer Pharmaceuticals, Schering Plough Research Institute, Shire Pharmaceuticals, Sumitomo Pharmaceuticals America Ltd, Takeda Industries, Transcept Pharmaceutical, UCB Pharma, US Micron, and Tetragenex Pharmaceuticals (compensation in exercisable warrant options until March 21, 2012; value less than $10 000), and he is a cosponsor on pending patents related to glutamatergic agents for psychiatric disorders (depression and obsessive-compulsive disorder) and antidepressant effects of oral ketamine.
Funding/Support: This work was supported by a Donaghue Foundation Clinical and Community Grant, an American Psychiatric Association Substance Abuse and Mental Health Services Administration grant, a Veterans Administration Research Enhancement Award Program award, and an American Foundation for Suicide Prevention Young Investigator Grant.
Role of the Sponsor: The funding sources played no role in the design or conduct of the study; collection management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.
Additional Contributions: The authors thank Sobia Sarmast, BA, and Michelle Streckenbach, BA, for technical support and the participating residents and program directors for the time that they invested in this study. They also thank the American Medical Association for providing demographic information about participating residency programs.
Create a personal account or sign in to: